| Molly Thornton, MS, CCC-SLP | |
|
2106 S Tate St Ste E, Corinth, MS 38834-7913 | |
| (662) 643-4043 | |
| (662) 643-4044 |
| Full Name | Molly Thornton |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 2106 S Tate St Ste E, Corinth, Mississippi |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902419419 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | S4199 (Mississippi) | Primary |
| Provider Name | Anchor Rehabilitation Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1922542646 PECOS PAC ID: 2961774047 Enrollment ID: O20170824001399 |
News Archive
The genetic code stored in DNA determines everything from the color of our eyes to our susceptibility to disease. This has motivated scientists to sequence the human genome and develop ways to alter the genetic code, but many diseases are linked to a different fundamental molecule: RNA.
Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, today announced the signature of an exclusive licence agreement with Novartis for the development, manufacture and commercialisation of Debio 025 (alisporivir), a selective, first-in-class cyclophilin (Cyp) inhibitor with a potent anti-hepatitis C virus (HCV) effect. The product is currently in phase 2b clinical development for the treatment of hepatitis C. Debiopharm granted Novartis worldwide commercialisation rights to Debio 025 except for Japan.
Subtle racism - which can include social slights and ambiguous remarks that are hard to pin down - is more dangerous to mental health than overt discrimination, according to a study of 180 Korean immigrants living in Canada.
South Asians are more likely to die of heart disease, such as heart attacks and strokes caused by atherosclerosis - the disease process that narrows arteries - than East Asians and non-Hispanic whites living in the United States, according to a new scientific statement from the American Heart Association published in its journal Circulation.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Molly Thornton, MS, CCC-SLP 2106 S Tate St Ste E, Corinth, MS 38834-7913 Ph: (662) 643-4043 | Molly Thornton, MS, CCC-SLP 2106 S Tate St Ste E, Corinth, MS 38834-7913 Ph: (662) 643-4043 |
News Archive
The genetic code stored in DNA determines everything from the color of our eyes to our susceptibility to disease. This has motivated scientists to sequence the human genome and develop ways to alter the genetic code, but many diseases are linked to a different fundamental molecule: RNA.
Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, today announced the signature of an exclusive licence agreement with Novartis for the development, manufacture and commercialisation of Debio 025 (alisporivir), a selective, first-in-class cyclophilin (Cyp) inhibitor with a potent anti-hepatitis C virus (HCV) effect. The product is currently in phase 2b clinical development for the treatment of hepatitis C. Debiopharm granted Novartis worldwide commercialisation rights to Debio 025 except for Japan.
Subtle racism - which can include social slights and ambiguous remarks that are hard to pin down - is more dangerous to mental health than overt discrimination, according to a study of 180 Korean immigrants living in Canada.
South Asians are more likely to die of heart disease, such as heart attacks and strokes caused by atherosclerosis - the disease process that narrows arteries - than East Asians and non-Hispanic whites living in the United States, according to a new scientific statement from the American Heart Association published in its journal Circulation.
› Verified 4 days ago
Ashlee Lucinda Manahan, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2106 S. Tate St., Suite E, Corinth, MS 38834 Phone: 622-643-4043 | |
Catherine Grace Pratt, SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 2203 Highway 72 E, Corinth, MS 38834 Phone: 662-872-3177 Fax: 662-872-3117 | |
Samantha Briggs, M.S., CF-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 2203 Highway 72 E, Corinth, MS 38834 Phone: 662-872-3177 | |
Mrs. Ruth A King, SPEECH PATHOLOGIST Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 1681 Viginia Lane, Corinth, MS 38834 Phone: 662-287-5662 Fax: 662-287-5663 | |
Emily Earnest Sanderson, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2106 S Tate St Ste E, Corinth, MS 38834 Phone: 662-643-4043 Fax: 662-643-4044 | |
Kaylee Crump, M.S. SLP-CF Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2106 S Tate St Ste E, Corinth, MS 38834 Phone: 662-643-4043 Fax: 662-643-4044 | |
Ivy Robbins, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2106 S Tate St Ste E, Corinth, MS 38834 Phone: 662-643-4043 Fax: 662-643-4044 |